What this means
This is a planned small trial that is still recruiting, and no results have been posted yet. It will compare the two treatments on each side of the face, but it cannot yet tell us which works better.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 50–65 · 10 women aged 50 to 65 at one clinic in Montreal
- Where
- 1 site
The science
- Registered title
- Ultraformer MPT Combined With Fractional CO2 Versus Fractional CO2 Alone for Facial Rejuvenation
- Trial ID
- NCT07896512 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Skin Aging
- What is tested
- Ultraformer MPT, SmartXide Tetra Pro fractional CO2 laser
- Sponsor
- Clinique Face MD
- Ages
- 50 Years to 65 Years
- Dates
- First posted Oct 27, 2026 · updated Oct 27, 2026
Registry summary
This pilot study compares fractional CO2 laser resurfacing alone with the same laser combined, in the same session, with micro-focused ultrasound (Ultraformer MPT) for signs of facial skin aging in women aged 50 to 65. Both devices are licensed by Health Canada and are used within their licensed indications.
Each participant's two facial sides are compared: one side, chosen at random, receives the combination and the other side receives the laser alone. The second side receives the ultrasound at Month 3, so both sides end with the combination. Ten participants are enrolled at one clinic in Montreal and followed for 6 months. As a pilot, the study estimates the size and variability of the difference between sides to inform a larger trial.
Sites (1)
- Clinique Face MD, Montreal, Quebec, Canada
Related treatments
Laser resurfacing (CO2 and fractional lasers) · Ultrasound skin lifting (Ultherapy)